Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Cannabis Cannabinoid Res ; 7(3): 318-327, 2022 06.
Article in English | MEDLINE | ID: mdl-34182795

ABSTRACT

Introduction: There is widespread acceptance of cannabis for medical or recreational use across the society, including pregnant women. Concerningly, numerous studies find that the developing central nervous system (CNS) is vulnerable to the detrimental effects of Δ9-tetrahydrocannabinol (THC). In contrast, almost nothing on the consequences of perinatal cannabidiol (CBD) exposure. In this study, we used mice to investigate the adult impact of perinatal cannabinoid exposure (PCE) with THC, CBD, or a 1:1 ratio of THC and CBD on behaviors. Furthermore, the lasting impact of PCE on fluoxetine sensitivity in the forced swim test (FST) was evaluated to probe neurochemical pathways interacting with the endocannabinoid system (ECS). Methods: Pregnant CD1 dams were injected subcutaneously daily with vehicle, 3 mg/kg THC, 3 mg/kg CBD, or 3 mg/kg THC +3 mg/kg CBD from gestational day 5 to postnatal day 10. Mass spectroscopic (MS) analyses were conducted to measure the THC and CBD brain levels in dams and their embryonic progenies. PCE adults were subjected to a battery of behavioral tests: open field arena, sucrose preference test, marble burying test, nestlet shredding test, and FST. Results: MS analysis found substantial levels of THC and CBD in embryonic brains. Our behavioral testing found that PCE females receiving THC or CBD buried significantly more marbles than control mice. Interestingly, PCE males receiving CBD or THC+CBD had significantly increased sucrose preference. While PCE with THC or CBD did not affect FST immobility, PCE with THC or CBD prevented fluoxetine from decreasing immobility in both males and females. Excitingly, fatty acid amide hydrolase (FAAH) inhibition with a dose of URB597 that was behaviorally inactive in the FST rescued fluoxetine efficacy in PCE mice of both sexes. Conclusions: Our data suggest that PCE with either THC, CBD, or THC+CBD alters repetitive and hedonic behaviors in a phytocannabinoid and sex-dependent manner. In addition, PCE with THC or CBD prevents fluoxetine from enhancing coping behavior. The restoration of fluoxetine responsiveness in THC or CBD PCE adults by inhibition of FAAH suggests that PCE causes a lasting reduction of the ECS and that enhancement of anandamide signaling represents a potential treatment for behavioral deficits following PCE.


Subject(s)
Cannabidiol , Cannabinoids , Fluoxetine , Amidohydrolases , Animals , Cannabidiol/adverse effects , Cannabinoids/adverse effects , Dronabinol/adverse effects , Drug Resistance , Female , Fluoxetine/pharmacology , Male , Mice , Pregnancy , Sucrose
2.
J Clin Pathol ; 63(7): 657-9, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20591917

ABSTRACT

Incontinentia pigmenti (IP) is a rare X-linked genodermatosis in which skin changes are combined with anomalies of other tissues, mainly of ectodermal origin. Mutations of the IKBKG gene are responsible for IP. Haematological disorders among IP patients are rare. Four female patients from a single family, with typical clinical characteristics of IP, are reported. In addition, all affected family members show a distinct haematological phenotype: hypogranular granulocytes, leucocytes with pseudoplatelets, and different anomalies of nuclei. Pseudoplatelets are a typical finding in patients with leukaemia. As there is dysfunction of the IKBKG gene in leukaemia, it is hypothesised that mis-regulation of the NEMO pathway may cause the appearance of pseudoplatelets in acute leukaemias as well as in IP. These observations suggest that IP may not be only linked to skin and organs of the ectodermal origin.


Subject(s)
Incontinentia Pigmenti/blood , Leukocytes/ultrastructure , Adult , Female , Humans , I-kappa B Kinase/genetics , Incontinentia Pigmenti/genetics , Male , Microscopy, Electron , Middle Aged , Pedigree
3.
Biol Reprod ; 66(5): 1403-12, 2002 May.
Article in English | MEDLINE | ID: mdl-11967204

ABSTRACT

Gap junctional intercellular coupling allows cells to share low molecular weight metabolites and second messengers, thus facilitating homeostatic and developmental processes. Gap junctions make their appearance very early in rodent development, during compaction in the eight-cell stage. Surprisingly, preimplantation mouse embryos lacking the gap junction protein connexin 43 develop normally and establish full-term pregnancies despite severely reduced gap junctional coupling. It was suggested that this might be explained by the presence of at least five additional connexins known to be expressed in blastocysts. In the present study, we set out to clarify the number of connexins present in preimplantation rodent embryos and the role of gap junctional coupling, if any, in blastocyst development. We provide evidence from reverse transcription-polymerase chain reaction analysis that the genes encoding 3 additional connexins (connexin 30 or beta6, connexin 36 or alpha9, and connexin 57 or alpha10) are also transcribed in preimplantation mouse embryos. Furthermore, we show that multiple connexins are expressed in rat preimplantation embryos, indicating that multiplicity of connexin expression may be a common feature of early mammalian embryogenesis. We could detect no up-regulation of any of 3 coexpressed connexins examined in mouse embryos lacking connexin 43. Impaired intercellular coupling caused either by the loss of connexin 43 or by treatment of cultured embryos with the gap junctional coupling blocker 18alpha-glycyrrhetinic acid (AGA) had no discernable effect on either apoptosis or glucose utilization, parameters known to be affected by gap junctional coupling in other contexts. These results, taken together with the reported inability of AGA to perturb blastocyst formation, imply that gap junctional coupling is not essential during this developmental period. We propose that connexin expression and the assembly of multiple types of gap junction channels in preimplantation embryos facilitates the diversification of communication pathways that will appear during postimplantation development. New evidence of this diversification is presented using rat blastocyst outgrowths.


Subject(s)
Blastocyst/physiology , Connexins/biosynthesis , Gap Junctions/physiology , Gene Expression Regulation, Developmental/physiology , Animals , Apoptosis/physiology , Blastocyst/cytology , Connexin 30 , Connexins/genetics , Connexins/physiology , Female , Fluorescent Antibody Technique, Direct , Gap Junctions/drug effects , Gene Expression Regulation, Developmental/genetics , Glucose/metabolism , Immunohistochemistry , In Situ Nick-End Labeling , Mice , Pregnancy , Pyruvic Acid/metabolism , Rats , Reverse Transcriptase Polymerase Chain Reaction , Signal Transduction/physiology , Gap Junction delta-2 Protein
4.
Eur J Biochem ; 268(6): 1749-59, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11248695

ABSTRACT

The connexin31 (Cx31) gene, a member of the connexin multigene family, is expressed in a characteristic spatiotemporal pattern during placental development in rodents. To elucidate the trophoblast-specific regulation of Cx31, we have isolated the rat Cx31 gene and performed structural and functional promoter analysis. The isolated Cx31 gene contains two exons separated by an intron of 2.6 kb. The first exon of the Cx31 gene is preceded by a TATA-less promoter region. Transcription is initiated in exon 1 from two transcription start sites producting transcripts of 105 and 139 bp. The 935 bp of the 5' flanking region of exon 1 comprises five putative binding sites for the GATA transcription factors as well as a NF-kappa B element, a CAAT-box and E-box/E-box-related sequences. For functional promoter analysis, the rat choriocarcinoma cell line Rcho-1 and the mouse keratinocyte cell line Hel37, which both express Cx31, were chosen. Only constructs including exon 1 and the complete intron showed high activity in transient transfection experiments in both cell lines. All deletion fragments of the putative promoter region, but which contain the entire intron sequence, did not reveal any obvious changes in luciferase activity. However, deletion of 1.1 kb of the intron sequence downstream of the splice donor site resulted in the loss of promoter activity. The intron exhibits no enhancer activity for the gene; however, the mRNA stability was increased in the presence of the intron sequence. These results indicate that parts of the intron sequence are critical for basic promoter function of the Cx31 gene.


Subject(s)
Connexins/genetics , Gene Expression Regulation , Introns , Animals , Base Sequence , Blotting, Northern , DNA , Exons , Fluorescent Antibody Technique , Genes, Reporter , Mice , Molecular Sequence Data , Plasmids , Promoter Regions, Genetic , RNA, Messenger/genetics , Rats , Transcription Factors/genetics , Transcription, Genetic
5.
Exp Cell Res ; 264(2): 397-407, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11262196

ABSTRACT

Bone cells form a functional syncytium as they are coupled by gap junctions composed mainly of connexin 43 (Cx43). To further understand the role of Cx43 in bone cell growth and differentiation, we stably transfected Cx45-expressing UMR 106-01 cells with Cx43 using an expression vector containing rat Cx43 cDNA. Three stably transfected clones were analyzed, all of which showed altered expression of Cx43 and/or Cx45 as was obvious from immunocytochemistry and Northern blotting. Double whole-cell patch clamping revealed single-channel conductances of 20 (Cx45) and 60 pS (Cx43). The overexpression of Cx43 led to an increase in dye coupling concomitant with elevated gap-junctional conductance. The phenotype of the transfected clones was characterized by an increased proliferation (4- to 7-fold) compared to controls. Moreover, a transfectant clone with 10- to 12-fold enhanced Cx43 expression showed a significantly increased calcium content of the extracellular matrix and enlarged mineralization nodules, while alkaline phosphatase was moderately increased. We conclude that enhanced gap-junctional coupling via Cx43 significantly promotes proliferation and differentiation of UMR cells.


Subject(s)
Connexin 43/biosynthesis , Osteoblasts/cytology , Alkaline Phosphatase/metabolism , Animals , Blotting, Northern/methods , Cell Adhesion/physiology , Cell Differentiation , Cell Division , Connexin 43/genetics , Electrophysiology , Gap Junctions/physiology , Gene Expression , Rats , Transfection , Tumor Cells, Cultured
6.
Laryngorhinootologie ; 80(12): 719-24, 2001 Dec.
Article in German | MEDLINE | ID: mdl-11793268

ABSTRACT

INTRODUCTION: Gap junction channels consist of different connexin proteins and play an important role in the physiology of hearing. Connexin26 and connexin30 have been demonstrated in the inner ear by immunohistochemistry and Northern Blot analysis. Mutations in the genes for connexin26 and connexin30 have been described to be responsible for non-syndromic hearing loss. METHODS: We investigated the prevalence of connexin26 and connexin30 mutations in patients with profound hearing loss or deafness by SSCP-analysis and sequencing. RESULTS: 30 connexin26 mutations (22 %) were detected among 134 patients with profound hearing loss or deafness. The most frequent connexin26 mutation 30delG was found in 25 patients. In 5 patients other connexin26 mutations were identified. No connexin30 mutation was found. CONCLUSION: Therefore connexin26 mutations also play an important role for non-syndromic hearing loss in Germany. We propose that every patient with suspected hereditary hearing loss should be screened for a connexin26 mutation.


Subject(s)
Connexins/genetics , Deafness/genetics , Ear, Inner/pathology , Mutation/genetics , Adolescent , Adult , Animals , Child , Child, Preschool , Connexin 26 , Connexin 30 , Deafness/embryology , Deafness/pathology , Ear, Inner/embryology , Female , Gap Junctions/genetics , Humans , Male , Polymorphism, Single-Stranded Conformational , Pregnancy , Pregnancy Trimester, Second , Rats , Rats, Wistar
7.
J Cell Biol ; 140(6): 1453-61, 1998 Mar 23.
Article in English | MEDLINE | ID: mdl-9508777

ABSTRACT

Mice that harbor a targeted homozygous defect in the gene coding for the gap junctional protein connexin26 died in utero during the transient phase from early to midgestation. From day 10 post coitum onwards, development of homozygous embryos was retarded, which led to death around day 11 post coitum. Except for growth retardation, no gross morphological alterations were detected between homozygous connexin26-defective embryos and wild-type littermates. At day 9 postcoitum, when chorioallantoic placenta started to function, connexin26 was weakly expressed in the yolk sac epithelium, between syncytiotrophoblasts I and II in the labyrinth region of the placenta, and in the skin of the embryo. At day 10 post coitum, expression of connexin26 in the placenta was much stronger than at the other locations. To analyze involvement of connexin26 in the placental transfer of nutrients, we have measured embryonic uptake of the nonmetabolizable glucose analogue 3-O-[14C]methylglucose, injected into the maternal tail vein. At day 10 post coitum, viable, homozygous connexin26-defective embryos accumulated only approximately 40% of the radioactivity measured in wild-type and heterozygous littermates of the same size. We conclude that the uptake of glucose, and presumably other nutrients as well, from maternal blood into connexin26-deficient mouse embryos was severely impaired and apparently not sufficient to support the rapid organogenesis during midgestation. Our results suggest that connexin26 gap junction channels likely fulfill an essential role in the transfer of maternal nutrients and embryonic waste products between syncytiotrophoblast I and II in the labyrinth layer of the mouse placenta.


Subject(s)
3-O-Methylglucose/pharmacokinetics , Connexins/genetics , Placenta/metabolism , Alleles , Animals , Carbon Radioisotopes , Connexin 26 , Connexins/deficiency , Epithelial Cells/chemistry , Epithelial Cells/cytology , Epithelial Cells/physiology , Female , Gap Junctions/chemistry , Heterozygote , Male , Mice , Mice, Inbred BALB C , Mice, Mutant Strains , Mutagenesis/physiology , Placenta/cytology , Pregnancy , RNA, Messenger/analysis , Skin/chemistry , Skin/cytology , Stem Cells/chemistry , Stem Cells/cytology , Stem Cells/physiology , Yolk Sac/chemistry , Yolk Sac/cytology
8.
Curr Biol ; 7(9): 713-6, 1997 Sep 01.
Article in English | MEDLINE | ID: mdl-9285723

ABSTRACT

Connexins are subunits of gap junction channels, which mediate the direct transfer of ions, second messenger molecules and other metabolites between contacting cells. Gap junctions are thought to be involved in tissue homeostasis, embryonic development and the control of cell proliferation [1,2]. It has also been suggested that the loss of intercellular communication via gap junctions may contribute to multistage carcinogenesis [3-5]. We have previously shown that transgenic mice that lack connexin32 (Cx32), the major gap junction protein expressed in hepatocytes, express lower levels of a second hepatic gap junction protein, Cx26, suggesting that Cx32 has a stabilizing effect on Cx26 [6]. Here, we report that male and female one-year-old mice deficient for Cx32 had 25-fold more and 8-fold more spontaneous liver tumors than wild-type mice, respectively. Incorporation of bromodeoxyuridine (BrdU) into the liver was higher for Cx32-deficient mice than for wild-type mice, suggesting that their hepatocyte proliferation rate was higher. Furthermore, intraperitoneal injection, two weeks after birth, of the carcinogen diethylnitrosamine (DEN) led, after one year, both to more liver tumors in Cx32-deficient mice than in controls, and to accelerated tumor growth. Loss of Cx32 protein from hepatic gap junctions is therefore likely to cause enhanced clonal survival and expansion of mutated ('initiated') cells, which results in a higher susceptibility to hepatic tumors. Our results demonstrate that functional gap junctions inhibit the development of spontaneous and chemically induced tumors in mouse liver.


Subject(s)
Connexins/physiology , Liver Neoplasms, Experimental/etiology , Animals , Blotting, Northern , Bromodeoxyuridine/metabolism , Carcinogens/pharmacology , Connexins/deficiency , Diethylnitrosamine/pharmacology , Female , Fluorescent Antibody Technique, Indirect , Incidence , Liver Neoplasms, Experimental/chemically induced , Male , Mice , Mice, Inbred C57BL , Gap Junction beta-1 Protein
9.
Proc Natl Acad Sci U S A ; 93(18): 9565-70, 1996 Sep 03.
Article in English | MEDLINE | ID: mdl-8790370

ABSTRACT

The gap junctional protein connexin32 is expressed in hepatocytes, exocrine pancreatic cells, Schwann cells, and other cell types. We have inactivated the connexin32 gene by homologous recombination in the mouse genome and have generated homozygous connexin32-deficient mice that were viable and fertile but weighed on the average approximately 17% less than wild-type controls. Electrical stimulation of sympathetic nerves in connexin32-deficient liver triggered a 78% lower amount of glucose mobilization from glycogen stores, when compared with wild-type liver. Thus, connexin32-containing gap junctions are essential in mouse liver for maximal intercellular propagation of the noradrenaline signal from the periportal (upstream) area, where it is received from sympathetic nerve endings, to perivenous (downstream) hepatocytes. In connexin32-defective liver, the amount of connexin26 protein expressed was found to be lower than in wild-type liver, and the total area of gap junction plaques was approximately 1000-fold smaller than in wild-type liver. In contrast to patients with connexin32 defects suffering from X chromosome-linked Charcot-Marie-Tooth disease (CMTX) due to demyelination in Schwann cells of peripheral nerves, connexin32-deficient mice did not show neurological abnormalities when analyzed at 3 months of age. It is possible, however, that they may develop neurodegenerative symptoms at older age.


Subject(s)
Connexins/physiology , Liver/innervation , Signal Transduction , Sympathetic Nervous System/physiology , Synaptic Transmission/physiology , Animals , Base Sequence , Charcot-Marie-Tooth Disease/physiopathology , Connexin 26 , Connexins/analysis , Connexins/deficiency , Electric Stimulation , Female , Freeze Fracturing , Gap Junctions/metabolism , Genotype , Glucose/metabolism , Liver/ultrastructure , Liver Glycogen/metabolism , Male , Mice , Microscopy, Electron , Molecular Sequence Data , Norepinephrine/pharmacology , Phenotype , Gap Junction beta-1 Protein
10.
N Z Med J ; 100(827): 407-8, 1987 Jul 08.
Article in English | MEDLINE | ID: mdl-3330586

ABSTRACT

A patient treated with disopyramide presented with hypoglycaemia, a raised serum insulin level and died of pneumonia. From these findings and a review of 10 case reports, we propose that disopyramide causes hypoglycaemia by stimulation of insulin release as described for the antimalarial drugs quinine and quinidine.


Subject(s)
Disopyramide/adverse effects , Hypoglycemia/chemically induced , Insulin/blood , Aged , Humans , Hypoglycemia/blood , Male , Stimulation, Chemical
SELECTION OF CITATIONS
SEARCH DETAIL
...